Cancer stem cells (CSCs) have been identified as rare cell populations in many cancers,
including leukemia and solid tumors. Accumulating evidence has suggested that CSCs are …

Abstract CD133 (prominin‐1) was the first in a class of novel pentaspan membrane proteins
to be identified in both humans and mice, and was originally classified as a marker of …

Cancers are heterogeneous at the cell level, and the mechanisms leading to cancer
heterogeneity could be clonal evolution or cancer stem cells. Cancer stem cells are resistant …

Background Cancer stem cells are associated with metastatic potential, treatment
resistance, and poor patient prognosis. Distant recurrence remains the major cause of …

Although CD133 has been shown to be a marker for cancer stem cells in various tumours, its
expression in pancreatic cancer has not yet been clinically reported. In this study, we …

Embryonic stem cells are immortal, can self renew, and differentiate into all cells of the body.
The adult organism maintains adult stem cells in regenerative organs that can differentiate …

AIM: To assess the role of circulating tumor cells (CTCs) and cancer stem cells (CSCs) in
hepatitis C virus (HCV)-associated liver disease. METHODS: Blood and/or tissue samples …

Recent evidence suggests that a subset of cells within a tumour have 'stem-
like'characteristics. These tumour-initiating cells, distinct from non-malignant stem cells …

Simple Summary The current theory of the prostate cancer stem cell (PCSC) may help us
understand cancer recurrence and treatment failure of prostate cancer, and CD133 is one of …

Cancer stem cells (CSC) are capable of promoting tumor initiation and self-renewal, two
important hallmarks of carcinoma formation. This population comprises a small percentage …